E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models. [electronic resource]
Producer: 20100330Description: 210-5 p. digitalISSN:- 1349-7006
- Aminopyridines -- therapeutic use
- Animals
- Antineoplastic Agents -- therapeutic use
- Cell Line, Tumor
- Disease Progression
- Female
- Humans
- Mice
- Neoplasms, Experimental -- drug therapy
- Phosphorylation
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Vascular Endothelial Growth Factor Receptor-2 -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.